Une candidature complète en une minute
Un CV et une lettre de motivation personnalisés, prêts à envoyer.
Guggenheim Securities seeks an exceptional candidate to join as a sell-side Equity Research Associate to cover the Biotechnology sector. The role involves following public/private biotech companies, supporting the research team in financial modeling, and making stock recommendations to institutional clients.
The position is based in New York or Boston with a hybrid schedule (in-office at least 4 days/week).
Guggenheim is seeking an exceptional candidate to join as a sell-side Equity Research Associate to help cover the Biotechnology sector. This person will be responsible for following the progress of public/private Biotechnology companies and will support the research team in its efforts to analyze companies and make stock recommendations to institutional investor clients. In addition to a background in the life sciences, the ideal candidate will have interest in equity research and financial modeling, specifically in the Biotechnology sectors with a focus on rare disease and gene therapies. The position is in New York or Boston.
Guggenheim Securities is the investment banking and capital markets business of Guggenheim Partners, a global investment and advisory firm. Guggenheim Securities offers services that fall into four broad categories: Advisory, Financing, Sales and Trading, and Research. Guggenheim Securities is headquartered in New York, with additional offices in Chicago, Boston, Atlanta, San Francisco, and Houston.
For more information, please visit GuggenheimSecurities.com, follow us on LinkedIn or contact us at GSLateralRecruiting@guggenheimpartners.com or 212.518.9200.
Guggenheim Securities, LLC (“GS”) does not accept unsolicited resumes or applications. GS considers any resume or application to be unsolicited if (a) received from an entity or individual without a current recruiting agreement with GS or (b) submitted to anyone at the firm other than through the process set forth in the recruiting agreement between GS and the submitting entity or individual, and GS will not pay a fee to any entity or individual for such submission.